Din FU - Search Results

1

Pharmacist-led counselling intervention to improve antiretroviral drug adherence in Pakistan: a randomized controlled trial.

Chatha ZF, Rashid U, Olsen S, Din FU, Khan A, Nawaz K, Gan SH, Khan GM. Chatha ZF, et al. Among authors: din fu. BMC Infect Dis. 2020 Nov 23;20(1):874. doi: 10.1186/s12879-020-05571-w. BMC Infect Dis. 2020. PMID: 33228562 Free PMC article. Clinical Trial.

2

Investigation of the treatment potential of Raloxifene-loaded polymeric nanoparticles in osteoporosis: In-vitro and in-vivo analyses.

Guo Z, Afza R, Moneeb Khan M, Khan SU, Khan MW, Ali Z, Batool S, Din FU. Guo Z, et al. Among authors: din fu. Heliyon. 2023 Sep 13;9(9):e20107. doi: 10.1016/j.heliyon.2023.e20107. eCollection 2023 Sep. Heliyon. 2023. PMID: 37810010 Free PMC article.

3

Sodium stibogluconate loaded nano-deformable liposomes for topical treatment of leishmaniasis: macrophage as a target cell.

Dar MJ, Din FU, Khan GM. Dar MJ, et al. Among authors: din fu. Drug Deliv. 2018 Nov;25(1):1595-1606. doi: 10.1080/10717544.2018.1494222. Drug Deliv. 2018. PMID: 30105918 Free PMC article.

4

Rifampicin-loaded nanotransferosomal gel for treatment of cutaneous leishmaniasis: passive targeting via topical route.

Rabia S, Khaleeq N, Batool S, Dar MJ, Kim DW, Din FU, Khan GM. Rabia S, et al. Among authors: din fu. Nanomedicine (Lond). 2020 Jan;15(2):183-203. doi: 10.2217/nnm-2019-0320. Epub 2020 Jan 9. Nanomedicine (Lond). 2020. PMID: 31916472

5

Development of levosulpiride-loaded solid lipid nanoparticles and their in vitro and in vivo comparison with commercial product.

Khaleeq N, Din FU, Khan AS, Rabia S, Dar J, Khan GM. Khaleeq N, et al. Among authors: din fu. J Microencapsul. 2020 Mar;37(2):160-169. doi: 10.1080/02652048.2020.1713242. Epub 2020 Jan 17. J Microencapsul. 2020. PMID: 31916886

6

Diagnostic and Treatment Strategies for COVID-19.

Jamshaid H, Zahid F, Din IU, Zeb A, Choi HG, Khan GM, Din FU. Jamshaid H, et al. Among authors: din fu, din iu. AAPS PharmSciTech. 2020 Aug 3;21(6):222. doi: 10.1208/s12249-020-01756-3. AAPS PharmSciTech. 2020. PMID: 32748244 Free PMC article. Review.

7

Nanotechnology based solutions for anti-leishmanial impediments: a detailed insight.

Jamshaid H, Din FU, Khan GM. Jamshaid H, et al. Among authors: din fu. J Nanobiotechnology. 2021 Apr 15;19(1):106. doi: 10.1186/s12951-021-00853-0. J Nanobiotechnology. 2021. PMID: 33858436 Free PMC article. Review.

8

A cutback in Imiquimod cutaneous toxicity; comparative cutaneous toxicity analysis of Imiquimod nanotransethosomal gel with 5% marketed cream on the BALB/c mice.

Jamshaid H, Din FU, Malik M, Mukhtiar M, Choi HG, Ur-Rehman T, Khan GM. Jamshaid H, et al. Among authors: din fu. Sci Rep. 2022 Aug 20;12(1):14244. doi: 10.1038/s41598-022-18671-1. Sci Rep. 2022. PMID: 35987944 Free PMC article.

9

Macrophage targeting of nitazoxanide-loaded transethosomal gel in cutaneous leishmaniasis.

Khalid H, Batool S, Din FU, Khan S, Khan GM. Khalid H, et al. Among authors: din fu. R Soc Open Sci. 2022 Oct 5;9(10):220428. doi: 10.1098/rsos.220428. eCollection 2022 Oct. R Soc Open Sci. 2022. PMID: 36249328 Free PMC article.

10

Transdermal delivery of allopurinol-loaded nanostructured lipid carrier in the treatment of gout.

Ali Z, Din FU, Zahid F, Sohail S, Imran B, Khan S, Malik M, Zeb A, Khan GM. Ali Z, et al. Among authors: din fu. BMC Pharmacol Toxicol. 2022 Nov 28;23(1):86. doi: 10.1186/s40360-022-00625-y. BMC Pharmacol Toxicol. 2022. Retraction in: BMC Pharmacol Toxicol. 2023 Jul 12;24(1):40. doi: 10.1186/s40360-023-00680-z PMID: 36443818 Free PMC article. Retracted.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68 results

Search Page

Filters